
FDA to investigate diabetes drug saxagliptin for possible heart failure risk
(HealthDay)—The U.S. Food and Drug Administration announced Tuesday that it will investigate possible links between the diabetes drug saxagliptin and a heightened risk for heart failure among users.
Feb 11, 2014
0
0